These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 172631

  • 21. Formation of angiotensin III from [des-Asp1]angiotensin I in the mesentric vasculature.
    Sexton JM, Britton SL, Beierwaltes WH, Fiksen-Olsen MJ, Romero JC.
    Am J Physiol; 1979 Aug; 237(2):H218-23. PubMed ID: 464116
    [Abstract] [Full Text] [Related]

  • 22. Characterization of angiotensin-mediated ACTH release.
    Sobel DO.
    Neuroendocrinology; 1983 Aug; 36(4):249-53. PubMed ID: 6306499
    [Abstract] [Full Text] [Related]

  • 23. Specific receptors for des-Asp1-angiotensin II (("angiotensin III") in rat adrenals.
    Devynck MA, Pernollet MG, Matthews PG, Khosla MC, Bumpus FM, Meyer P.
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4029-32. PubMed ID: 198814
    [Abstract] [Full Text] [Related]

  • 24. A hexapeptide angiotensin antagonist, Des-(Asp1, Arg2), Ile8)-angiotensin II.
    Hirata M, Watanabe K, Nara M, Hattori E, Arakawa K.
    Endocrinol Jpn; 1975 Dec; 22(6):567-9. PubMed ID: 1231996
    [Abstract] [Full Text] [Related]

  • 25. Characterization of immunoreactive angiotensin in canine cerebrospinal fluid as Des-Asp1-angiotensin II.
    Hutchinsón JS, Csicsmann J, Korner PI, Johnston CI.
    Clin Sci Mol Med; 1978 Feb; 54(2):147-51. PubMed ID: 620503
    [Abstract] [Full Text] [Related]

  • 26. Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat.
    Garrison EA, Santiago JA, Osei SY, Kadowitz PJ.
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2418-25. PubMed ID: 7611494
    [Abstract] [Full Text] [Related]

  • 27. The importance of residues 2 (arginine) and 6 (histidine) in high-affinity angiotensin II antagonists.
    Samanen J, Brandeis E, Narindray D, Adams W, Cash T, Yellin T, Regoli D.
    J Med Chem; 1988 Apr; 31(4):737-41. PubMed ID: 3351849
    [Abstract] [Full Text] [Related]

  • 28. Modulation of adrenergic transmission by angiotensins in the perfused rat mesentery.
    Campbell WB, Jackson EK.
    Am J Physiol; 1979 Feb; 236(2):H211-7. PubMed ID: 217278
    [Abstract] [Full Text] [Related]

  • 29. Competitive binding activity of angiotensin II analogues in an adrenal cortex radioligand-receptor assay;
    Saltman S, Baukal A, Waters S, Bumpus FM, Catt KJ.
    Endocrinology; 1975 Aug; 97(2):275-82. PubMed ID: 169121
    [Abstract] [Full Text] [Related]

  • 30. Synthesis of nonmammalian angiotensins and their comparative pressor properties in dogfish shark, domestic chicken, and rat.
    Khosla MC, Bumpus FM, Nishimura H, Opdyke DF, Coviello A.
    Hypertension; 1983 Aug; 5(6 Pt 3):V22-8. PubMed ID: 6654463
    [Abstract] [Full Text] [Related]

  • 31. Steroidogenic and pressor activity of angiotensin analogues in the rat.
    Khairallah PA, Khosla MC, Bumpus FM, Tait JF, Tait SA.
    Clin Sci Mol Med Suppl; 1978 Dec; 4():175s-177s. PubMed ID: 282047
    [Abstract] [Full Text] [Related]

  • 32. [des-Asp1]angiotensin II in the dog: blood levels and effect on aldosterone.
    Semple PF, Nicholls MG, Tree M, Fraser R.
    Endocrinology; 1978 Oct; 103(4):1476-82. PubMed ID: 744159
    [Abstract] [Full Text] [Related]

  • 33. Characterization of angiotensin receptors on bovine adrenal fasciculata cells.
    Vallotton MB, Capponi AM, Grillet C, Knupfer AL, Hepp R, Khosla MC, Bumpus FM.
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):592-6. PubMed ID: 6264451
    [Abstract] [Full Text] [Related]

  • 34. Pathogenic factors involved in renovascular hypertension. State of the art.
    Bumpus FM, Khosla MC.
    Mayo Clin Proc; 1977 Jul; 52(7):417-23. PubMed ID: 327161
    [Abstract] [Full Text] [Related]

  • 35. In vivo conversion of [des-Asp1]-angiotensin I to [des-Asp1]-angiotensin II in conscious sheep.
    Fei DT, Coghlan JP, Scoggins BA, Tresham JJ.
    Clin Exp Pharmacol Physiol Suppl; 1982 Jul; 7():41-4. PubMed ID: 6754185
    [Abstract] [Full Text] [Related]

  • 36. A glial high-affinity binding site with specificity for angiotensin II not angiotensin III: a possible N-terminal-specific converting enzyme.
    Printz MP, Jennings C, Healy DP, Kalter V.
    J Cardiovasc Pharmacol; 1986 Jul; 8 Suppl 10():S62-8. PubMed ID: 2438494
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of octa- and heptapeptide antagonists of angiotensin II as inhibitors of angiotensin III binding in the rat adrenal glomerulosa.
    Douglas JG, Khosla MC, Bumpus FM.
    Endocrinology; 1985 Apr; 116(4):1598-602. PubMed ID: 3971929
    [Abstract] [Full Text] [Related]

  • 38. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW, Roberts KA, Cook VI, Murray CE, Sardinia MF, Harding JW.
    Brain Res; 1990 Apr 23; 514(1):5-10. PubMed ID: 2357530
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of angiotensin-converting enzyme by des-Leu10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme regulation.
    Snyder RA, Wintroub BU.
    Biochim Biophys Acta; 1986 May 12; 871(1):1-5. PubMed ID: 3008847
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.